News

Clinops leaders share thoughts on the upcoming year for industry.

With large shift to decentralized strategies, industry roles appear set for change.

Strategikon pharma completes sponsor suite of SaaS-based tools with VISION application.

Acquisition will integrate Tryl's patient engagement solutions.

Consortium will integrate clinical research site and sponsor technology.

Acquisition of oncology CRO will expand upon existing partnerships.

Research sector of Thermo Fisher collaborates with Medidata to advance site selection and recruitment.

Partnership will utilize Medable's trial software platform to enhance access.

Partnership will continue to enhance decentralized trials.

New software solution to simplify customer site payment process.

Recruiting software for HCPs now available in three rheumatological areas.

New all-in-one solution to increase compliance and accuracy.

New partnership will advance patient centricity via Seqster's patient engagement platform.

Acquisition to expand global engineering team and European presence.

New solution provides management of drug safety, pharmacovigilance, and safety reporting technology.

New RWE-based product will accelerate recruitment within underrepresented populations.

New partnership will expand Circuit Clinical's DCT network.

New solution looks to improve recruitment, compliance, and retention.

Pandemic sparks new long-term plan for success in R&D.

Data, patient recruitment, and regulators all highlighted in these three predictions for the new year.

Acquisition to expand clinical trial expertise through technology and patient centricity.

New HL7 standards enable access to EHR data to accelerate clinical research and digital trials.

New partnership to bring increased efficiency and patient centricity in trial execution.

Data also show COVID-19 to be second most studied disease area, and further highlight patient enrollment challenges.